100 related articles for article (PubMed ID: 4990022)
1. Carbenicillin: how useful?
Kass EH
J Infect Dis; 1970 Sep; 122():Suppl:S115-6. PubMed ID: 4990022
[No Abstract] [Full Text] [Related]
2. In-vitro activity of carbenicillin and results of treatment of infections due to Pseudomonas with carbenicillin singly and in combination with gentamicin.
Smith CB; Wilfert JN; Dans PE; Kurrus TA; Finland M
J Infect Dis; 1970 Sep; 122():Suppl:S14-28. PubMed ID: 4990023
[No Abstract] [Full Text] [Related]
3. Carbenicillin: chemistry and mode of action.
Butler K; English AR; Ray VA; Timreck AE
J Infect Dis; 1970 Sep; 122():Suppl:S1-8. PubMed ID: 4248289
[No Abstract] [Full Text] [Related]
4. R factors, beta-lactamase, and carbenicillin-resistant Pseudomonas aeruginosa.
Sykes RB; Richmond MH
Lancet; 1971 Aug; 2(7720):342-4. PubMed ID: 4105047
[No Abstract] [Full Text] [Related]
5. The nature of carbenicillin resistance in Pseudomonas aeruginosa.
Thomas AH; Broadbridge RA
J Gen Microbiol; 1972 Apr; 70(2):231-41. PubMed ID: 4624990
[No Abstract] [Full Text] [Related]
6. [Bacteriological studies of carbenicillin].
Nakazawa S; Ono H; Wajima G; Izawa T
Jpn J Antibiot; 1972 Feb; 25(1):21-7. PubMed ID: 4337674
[No Abstract] [Full Text] [Related]
7. Beta-lactamase and the resistance of Pseudomonas aeruginosa to various penicillins and cephalosporins.
Garber N; Friedman J
J Gen Microbiol; 1970 Dec; 64(3):343-52. PubMed ID: 4325086
[No Abstract] [Full Text] [Related]
8. Carbenicillin, a new semisynthetic penicillin active against Pseudomonas aeruginosa.
Rolinson GN; Sutherland R
Antimicrob Agents Chemother (Bethesda); 1967; 7():609-13. PubMed ID: 4970205
[No Abstract] [Full Text] [Related]
9. Carbenicillin: a new semisynthetic penicillin active against Pseudomonas pyocyanea.
Knudsen ET; Rolinson GN; Sutherland R
Br Med J; 1967 Jul; 3(5557):75-8. PubMed ID: 4961466
[No Abstract] [Full Text] [Related]
10. Use of carbenicillin in patients with cystic fibrosis.
Boxerbaum B; Doershuk CF; Matthews LW
J Infect Dis; 1970 Sep; 122():Suppl:S59-61. PubMed ID: 4990025
[No Abstract] [Full Text] [Related]
11. [Bacteriologic studies with carbenicillin].
Blasius C; Menz HP; Sander J
Dtsch Med Wochenschr; 1969 Nov; 94(48):2501-4. PubMed ID: 4981855
[No Abstract] [Full Text] [Related]
12. Clinical and microbiologic studies of carbenicillin.
Michaeli D; Weinstein L
J Infect Dis; 1970 Sep; 122():Suppl:S90-5. PubMed ID: 4990026
[No Abstract] [Full Text] [Related]
13. Intravenous administration of carbenicillin for septicemia due to Pseudomonas aeruginosa following thermal injury.
Curreri PW; Lindberg RB; DiVincenti FC; Pruitt BA
J Infect Dis; 1970 Sep; 122():Suppl:S40-7. PubMed ID: 4990024
[No Abstract] [Full Text] [Related]
14. Susceptibility of Proteus species and Pseudomonas aeruginosa to penicillins and cephalosporins.
Adler JL; Burke JP; Wilcox C; Finland M
Antimicrob Agents Chemother (Bethesda); 1970; 10():63-7. PubMed ID: 5000270
[No Abstract] [Full Text] [Related]
15. Combined action of beta-lactum antibiotics against gram-negative bacilli.
Bobrowski MM; Gebicka K; Borowski J
J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):129-40. PubMed ID: 4199760
[No Abstract] [Full Text] [Related]
16. In vitro susceptibility and resistance of gram negative bacilli to carbenicillin.
Athar MA
Hindustan Antibiot Bull; 1970; 13(1):1-7. PubMed ID: 4993698
[No Abstract] [Full Text] [Related]
17. Optimal dosage regimen for penicillins: bolus or continuous infusion?
Curcio L
J Antimicrob Chemother; 1979 Sep; 5(5):503-9. PubMed ID: 115829
[No Abstract] [Full Text] [Related]
18. [Sensitivity of strains of Pseudomonas aeruginosa to carbenicillin (pyopen)].
Teodorovici G; Zvorişteanu V; Strat E; Groll M
Rev Med Chir Soc Med Nat Iasi; 1972; 76(1):89-94. PubMed ID: 4622749
[No Abstract] [Full Text] [Related]
19. [Beta-lactamine associations. In vitro synergism and clinical results].
Acar JF
Pathol Biol (Paris); 1971; 19(11):593-7. PubMed ID: 4997292
[No Abstract] [Full Text] [Related]
20. [Carbenicillin. Experimental studies on the antibacterial activity and clinical pharmacology].
Naumann P; Kempf J
Arzneimittelforschung; 1969 Aug; 19(8):1222-33. PubMed ID: 4980237
[No Abstract] [Full Text] [Related]
[Next] [New Search]
